Paul A. Friedman
2019 - Synta Pharmaceuticals
In 2019, Paul A. Friedman earned a total compensation of $6.1M as Chairman and Chief Executive Officer at Synta Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $387,192 |
|---|---|
| Option Awards | $5,122,000 |
| Salary | $584,000 |
| Total | $6,093,192 |
Friedman received $5.1M in option awards, accounting for 84% of the total pay in 2019.
Friedman also received $387.2K in non-equity incentive plan and $584K in salary.
Rankings
In 2019, Paul A. Friedman's compensation ranked 1,662nd out of 13,971 executives tracked by ExecPay. In other words, Friedman earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,662 out of 13,971 | 88th |
Division Manufacturing | 593 out of 5,692 | 90th |
Major group Chemicals And Allied Products | 180 out of 2,189 | 92nd |
Industry group Drugs | 145 out of 1,875 | 92nd |
Industry Pharmaceutical Preparations | 108 out of 1,387 | 92nd |
Pay ratio
| Paul A. Friedman's Pay | $6,093,192 |
|---|---|
| Median Employee's Pay | $791,000 |
| Pay Ratio | 8to 1 |
In 2019, the annual total compensation of Paul A. Friedman was $6,093,192.
The annual total compensation of the median employee at Synta Pharmaceuticals was $791,000.
The ratio of Paul A. Friedman's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 29, 2020.
Friedman's colleagues
We found four more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2019.